IA
AMAG

IFP Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

IFP Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20
Closed – – 3747
2018
Q4 		$0 Hold
20
– – ﹤0.01% 3997
2018
Q3 		$0 Hold
20
– – ﹤0.01% 4111
2018
Q2 		$0 Hold
20
– – ﹤0.01% 4148
2018
Q1 		$0 Hold
20
– – ﹤0.01% 3875
2017
Q4 		$0 Hold
20
– – ﹤0.01% 4232
2017
Q3 		$0 Hold
20
– – ﹤0.01% 4290
2017
Q2 		$0 Hold
20
– – ﹤0.01% 4289
2017
Q1 		$0 Hold
20
– – ﹤0.01% 4209
2016
Q4 		$1K Hold
20
– – ﹤0.01% 3894
2016
Q3 		$0 Hold
20
– – ﹤0.01% 4124
2016
Q2 		$0 Buy
+20
New +$459 ﹤0.01% 4173
2016
Q1 		– Sell
-647
Closed -$20K – 3736
2015
Q4 		$20K Buy
+647
New +$20.9K ﹤0.01% 2176

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

IFP Advisors's AMAG Position: Q1 2019 in Review

IFP Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 20 shares.

IFP Advisors first reported a position in AMAG in Q4 2015 and held it in 12 quarters. The position peaked at $20K in Q4 2015. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

  • IFP Advisors reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • IFP Advisors sold 20 AMAG Pharmaceuticals shares in Q1 2019.
  • IFP Advisors first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 12 quarters.
  • IFP Advisors's AMAG Pharmaceuticals position peaked at $20K in Q4 2015.
  • 166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.